Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
9.11
+0.09 (1.00%)
At close: Nov 22, 2024, 4:00 PM
8.97
-0.14 (-1.54%)
After-hours: Nov 22, 2024, 7:59 PM EST
Anavex Life Sciences Cash Flow Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 |
| Net Income | -41.53 | -47.51 | -47.98 | -37.91 | -26.28 | -26.29 | |
| Other Amortization | - | - | - | - | - | 0.15 | |
| Stock-Based Compensation | 10.61 | 16.37 | 18.38 | 8.23 | 4.88 | 6.43 | |
| Other Operating Activities | -0.06 | 0.85 | - | - | - | -0.12 | |
| Change in Accounts Payable | -0.59 | 0.5 | -0.91 | 0.75 | 0.47 | 0.68 | |
| Change in Unearned Revenue | - | 0.47 | - | 0.44 | - | - | |
| Change in Other Net Operating Assets | 1.56 | 1.54 | 6.28 | -1.9 | -0.35 | 0.62 | |
| Operating Cash Flow | -30 | -27.79 | -24.24 | -30.38 | -21.29 | -18.53 | |
| Issuance of Common Stock | 13.94 | 29.65 | 22 | 158.79 | 28.75 | 17.83 | |
| Other Financing Activities | - | - | -0.71 | -5.55 | -0.4 | -0.05 | |
| Financing Cash Flow | 13.94 | 29.65 | 21.29 | 153.24 | 28.35 | 17.78 | |
| Net Cash Flow | -16.06 | 1.87 | -2.95 | 122.86 | 7.06 | -0.75 | |
| Free Cash Flow | -30 | -27.79 | -24.24 | -30.38 | -21.29 | -18.53 | |
| Free Cash Flow Per Share | -0.36 | -0.35 | -0.32 | -0.44 | -0.37 | -0.38 | |
| Cash Income Tax Paid | 0.15 | 0.14 | 0.33 | 0.14 | 0.02 | - | |
| Levered Free Cash Flow | -19.06 | -14.27 | -6.03 | -15.9 | -11.7 | -8.94 | |
| Unlevered Free Cash Flow | -19.06 | -14.27 | -6.03 | -15.9 | -11.7 | -8.94 | |
| Change in Net Working Capital | -0.91 | -2.51 | -5.38 | 0.72 | -0.12 | -1.13 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.